Sr. Director - Ecoa Program Lead

Eli Lilly Eli Lilly · Pharma · Indianapolis, IN

This role is a Sr. Director level Program Lead for eCOA (electronic Clinical Outcome Assessments) within a specific therapeutic area at Eli Lilly. The role involves leading the strategy, delivery, governance, and continuous improvement of eCOA capabilities, serving as a senior point of contact between eCOA teams and clinical development stakeholders. Responsibilities include advising leadership, anticipating needs, resolving complex issues, managing escalations, contributing to platform strategy and roadmap, ensuring inspection readiness, and driving capability development. The role requires a strong background in clinical data management or drug development within the pharmaceutical/biotech/CRO industry, with preferred qualifications including experience with modern data technologies like AI/ML, RPA, and cloud systems, as well as familiarity with regulatory requirements like GCP and 21 CFR Part 11.

What you'd actually do

  1. Serve as the primary eCOA authority for the therapeutic area — providing guidance to DnA Senior Directors, Clinical Development Leaders, and CDDA partners
  2. Develop deep familiarity with the TA's clinical pipeline, indication package status, and Disease State Measurement Strategy — anticipating eCOA needs before they become issues
  3. Build and implement eCOA delivery strategies for the TA, contributing to platform selection and integrated functional sourcing
  4. Own resolution and the leadership communications for eCOA issues in the TA
  5. Partner with DnA, Clinical Capabilities, and Quality teams to maintain inspection readiness across eCOA delivery in the TA

Skills

Required

  • Bachelor's degree in life sciences, data science, computer science, or a related STEM field with 10+ years of experience in clinical data management, clinical drug development, or a related field within pharmaceutical, biotech, or CRO industry
  • Masters in life sciences, data science, computer science, or a related STEM field with 7+ years of experience in clinical data management, clinical drug development, or a related field within pharmaceutical, biotech, or CRO industry

Nice to have

  • Experience in a senior advisory, SME, or portfolio leadership role within a therapeutic area
  • Familiarity with Disease State Measurement Strategy (DSMS) development and its application to eCOA and study design
  • Background in inspection support, audit readiness, or regulatory submissions related to eCOA or clinical data
  • Experience with modern data technologies in clinical development (AI/ML, RPA, cloud-based systems)
  • Familiarity with external eCOA standards bodies (e.g., C-Path, TransCelerate, FDA PRO guidance)
  • Deep understanding of Lilly's clinical development processes, CDDA operating model, and Atom5 platform
  • Proven ability to work independently in a complex, matrixed environment — setting direction and influencing without direct authority
  • Strong track record of cross-functional partnership across Clinical Development, Data Management, Tech@Lilly, and Quality
  • Deep understanding of CDM processes and regulatory requirements, including GCP, 21 CFR Part 11, and CDISC standards
  • Experience driving process improvement initiatives with measurable outcomes

What the JD emphasized

  • GCP
  • 21 CFR Part 11